Central venous catheters are medical devices that are inserted into large central veins and are used for various purposes such as administration of fluids, medications, blood products, and parenteral nutrition. Central venous catheters also find wide use in acute care situations such as surgeries or other medical conditions that require frequent IV access or administration of irritant medications. The growing prevalence of chronic and life-threatening diseases such as cancer, renal disorders, and cardiovascular diseases is driving the demand for central venous catheters for various therapeutic and diagnostic procedures.

The global Central Venous Catheter Market is estimated to be valued at US$ 2388.55 million in 2023 and is expected to exhibit a CAGR of 3.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity
The rising incidence of chronic diseases such as cancer, cardiovascular diseases, and renal disorders has increased the demand for central venous catheters, as these medical devices help facilitate long-term venous access for various therapeutic interventions in patients with chronic illnesses. According to the Centers for Disease Control and Prevention (CDC), in the U.S., over 690,000 people die from heart disease annually, making it the leading cause of death. Similarly, the American Cancer Society estimates that in 2023 there will be over 1.9 million new cancer cases diagnosed in the U.S. The growing patient pool of chronic and life-threatening diseases is expected to drive increased demand for central venous catheters and significantly boost the growth of the market over the forecast period.

Porter's Analysis

Threat of new entrants: Low as it requires significant investment and expertise to enter the central venous catheter market. Clinical trials and regulatory approvals also pose as barriers.

Bargaining power of buyers: Moderate as major hospitals have increasing bargaining power. However, need for catheters limits switching.

Bargaining power of suppliers: Moderate to high as a few specialized manufacturers dominate the supply of catheter components.

Threat of new substitutes: Low as no cost-effective substitute for catheters currently exists in critical care applications.

Competitive rivalry: High rivalry among existing players to gain market share through product innovation, partnerships and geographic expansion.

SWOT Analysis

Strengths: Growing geriatric population and rise in chronic diseases drive demand. Repeated use nature increases recurrent sales.

Weaknesses: Risk of infections associated with catheter use. Requirement of skilled professionals for insertion.

Opportunities: Rising demand in emerging nations offer scope. Development of antimicrobial catheters presents opportunities.

Threats: Stringent regulations delay product approvals. Reimbursement issues in developing countries hamper market growth.

Key Takeaways

The global central venous catheter market size is expected to witness high growth over the forecast period. The global Central Venous Catheter Market is estimated to be valued at US$ 2388.55 Mn in 2023 and is expected to exhibit a CAGR of 3.6% over the forecast period 2023 to 2030.

North America dominates market currently due to high healthcare spending and presence of major players. However, Asia Pacific is anticipated to grow at fastest pace owing to improving healthcare infrastructure and increasing medical tourism.

Key players operating in the central venous catheter market are Albemarle Corporation (US), W R Grace (US), BASF (Germany), Haldor Topsoe (Denmark), Honeywell UOP (US), Clariant (Switzerland), Axens (France), Johnson Matthey (UK), China Petroleum and Chemical Corporation (Sinopec) (China), and Shell Catalyst & Technologies (Netherlands), Arkema (France), Anten Chemicals (China), Chempack (China), Dorf-Ketal Chemicals Pvt. Ltd. (India), Exxon Mobil Corporation (US), Gazprom (Russia), JGC Catalyst and Chemicals (Japan),KNT Group (Russia), Kuwait Catalyst (Kuwait), N.E.Chemcat (Japan), Porocel (US), Qingdao Huicheng Environmental Technology (China), Taiyo Koko Co. Ltd. (Japan), Unicat Catalyst Technologies (US), and Yueyang Sciensun Chemicals (China). Major players are involved in new product launches and collaborations to gain edge.

Get more insights on this topic: https://creativenewsalert.blogspot.com/2023/12/the-global-central-venous-catheter.html